Abstract

In December 2019, the FDA approved the new antipsychotic drug lumateperone tosylate. In an industry-sponsored, 1-month, randomized clinical trial,

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call